Koers Jounce Therapeutics, Inc.
Aandelen
JNCE
US4811161011
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Michael Hearne
DFI | Director of Finance/CFO | - | - |
Eric Laub
IRC | Investor Relations Contact | - | 01-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.00% | 18 M€ | +3,48% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,49% | 105 mld. | |
+3,31% | 97,5 mld. | |
+1,66% | 22,19 mld. | |
-16,16% | 21,33 mld. | |
-6,82% | 18,68 mld. | |
-41,41% | 16,6 mld. | |
-22,87% | 14,52 mld. | |
+6,32% | 14,09 mld. | |
+21,46% | 10,99 mld. |